Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: U-13C-glucose
Sponsor: Rutgers, The State University of New Jersey
Collaborators: Ludwig Institute for Cancer Research